Easy Access and Express Report Delivery Service
Epigenetic Market, Global Outlook and Forecast 2024-2030
Report ID
47338
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
64
Editor's Rating
-
Report Details
The global Epigenetic market is projected to reach US$ 11230 million by 2030. Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence. This report contains market size and forecasts of Epigenetic in Global, including the following market information: Global Epigenetic Market Size 2025-2030, ($ millions) The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epigenetic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Epigenetic Market, by Type, 2025-2030 ($ millions) Global Epigenetic Market Segment Percentages, by Type Reagents Kits Instruments Enzymes Services Global Epigenetic Market, by Application, 2025-2030 ($ millions) Global Epigenetic Market Segment Percentages, by Application Academic Research Institutes Biotechnology Companies Biopharmaceutical Companies Diagnostic Companies Global Epigenetic Market, By Region and Country, 2025-2030 ($ Millions) Global Epigenetic Market Segment Percentages, by region and country United States Europe Asia China Rest of World Competitor Analysis The report also provides analysis of leading market participants including: Further, the report presents profiles of competitors in the market, key players include: Illumina Qiagen Abcam Merck & Co Sigma-Aldrich New England Biolabs Thermo Fisher Scientific Diagenode Active Motif Roche Diagnostics Eisai Novartis
